Authors


F.J. Quinn, Contributing Editor

Latest:

New cold chain solutions meet regulatory, shipper requirements

Cold chain packagers balance cost, performance and compliance approaches


Suzanne Shelley, Contributing Editor

Latest:

Specialty Pharmacy: The Trends Shaping Best Practices

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.


Frank Celia, Contributing Editor

Latest:

Pharma ups the ante on DTC advertising

Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television


Rob Ririe, Blue Fin Group

Latest:

Managing government pricing programs

When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences



Jennifer Fillman, Cardinal Health Specialty Solutions

Latest:

Getting products to market fast with the 3PL Title Model

A contractual arrangement that could save time and money for brand owners


Heather Morel, PhD, SVP/GM, Access & Adherence, RxCrossroads by McKesson

Latest:

Evolving Patient Access Programs for Specialty Therapies

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies


Larri Short, Arent Fox

Latest:

Lessons learned on bona fide service fees and fair market value-is there a 'right answer'?

Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial


Barry Fortner, ION Solutions, AmerisourceBergen Specialty Group

Latest:

Why community oncology matters

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products


Arno Sosna, Veeva Systems

Latest:

Machine learning finds purpose in commercial life sciences

Machine learning offers business knowledge based on the data that marketers and sales teams generate



By Rob Stevens, Tive

Latest:

Data logging is not enough for a modern pharma supply chain

IoT takes you from living in the past to shaping the future


By Will Febbo, OptimizeRx

Latest:

Connecting with physicians—and patients—at the point of care

Integrating pharma communications with electronic health-record systems brings value to patients and providers


Morna White, Quintiles

Latest:

The Rising Importance of Observational Research

International efforts to standardize guidelines for observational research could move the entire field forward


Sally Lorimer, ZS Associates, Inc.

Latest:

Change is a constant for sales incentive planning

Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions



V. James Mercante, Partners, TGaS Advisors

Latest:

The Five Things We Need to Do to Re-invent Commercial Operations

By running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance


Mike McCarthy

Latest:

Managing government pricing programs

When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences


Louise Parmenter

Latest:

The Rising Importance of Observational Research

International efforts to standardize guidelines for observational research could move the entire field forward



Jessica Randolph, Two Labs

Latest:

3PL selection as part of product launch process

The importance of partners being flexible and optimizing their processes in today's virtual climate



Suzanne Shelley, Pharmaceutical Commerce contributing editor

Latest:

Specialty pharmacy accreditation — burden and benefit

Accreditation status is both an entry ticket and a competitive measure for specialty pharmacies to attract manufacturer attention



Kevin Michels-Kim, The Stem

Latest:

Digital opinion leaders (DOLs) and their role in pharma markets

Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign


Greg Rotz

Latest:

Focusing pharma marketing on 'headroom'

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'


Jonathan Davies, PhD, Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Latest:

Follow-on Biologics: A Patent Litigation Perspective

In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully


Greg Page, Deloitte Consulting LLP

Latest:

Managing quality risks across the pharmaceutical supply chain

Well designed quality systems follow the product life cycle and foster a culture of quality


Tony Dellumo, QProducts & Services

Latest:

Cold chain capacity crisis looms ahead of Covid-19 vaccine rollout. Are you prepared?

Top players from cold chain logistics’ pharma, biologics, and life sciences sector sound alarm on the upcoming burden on temperature-controlled shipping capacity as the global supply chain plans for the safe distribution of Covid-19 vaccines requiring strict temperature management, some as cold as -20 to -30⁰C.


Regina Murphy, McKesson Specialty Care Solutions

Latest:

Dealing With REMS Challenges in Drug Commercialization

Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations

© 2025 MJH Life Sciences

All rights reserved.